Algorae Pharmaceuticals LimitedASX: 1AI

Algorae Receives A$318,771 R&D Cash Rebate from ATO

· Issued by Algorae Pharmaceuticals Limited

Filed with ASX · · 1 page · English

Summary by 6ix AI

The funds will be strategically used to advance Algorae's artificial intelligence-driven drug discovery programs and support early revenue opportunities. This announcement highlights Algorae's commitment to leveraging AI for pharmaceutical innovation and the development of novel drug candidates.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Algorae Pharmaceuticals Limited on 6ix

Story so far

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases